文献速递外周动脉疾病

长段股腘动脉闭塞的原发病变与既往腔内治疗病变采用原位大隐静脉旁路术后的比较

Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass.
PubMed 文献 · J Vasc Surg · 2022-05-11

基于LIMBSAVE前瞻性多中心观察性登记,比较股腘动脉闭塞原发病变(DN组341例)与既往腔内治疗病变(PE组119例)行原位大隐静脉旁路术的2年结果。两组在初次通畅率、辅助初次通畅率、二次通畅率和保肢率上均无显著差异。结论认为既往腔内治疗失败后行原位大隐静脉旁路术未显示总体通畅率和保肢率恶化,与既往文献报道相反。

要点

  • 2年随访时初次通畅率DN组66.3% vs PE组74.1%,无显著差异(P=.9)。
  • 2年辅助初次通畅率DN组78.2% vs PE组79.5%,无显著差异(P=.2)。
  • 2年二次通畅率DN组85.1% vs PE组91.4%、保肢率DN组95.2% vs PE组95.1%,均无显著差异。

核心结论

  • LIMBSAVE登记未显示长段股腘动脉闭塞性病变腔内治疗失败后行原位大隐静脉旁路术的患者在2年随访时总体通畅率和保肢率恶化。
  • 该发现与已发表的文献结论相反。

研究设计与样本

  • 基于LIMBSAVE登记的前瞻性、多中心、观察性研究,该登记针对以膝下旁路采用原位大隐静脉技术治疗威胁性肢体缺血的策略。
  • 2018年1月至2019年12月,43个中心共入组541例患者,本研究纳入其中460例:原发病变组(DN组)341例(74.1%),既往腔内治疗病变组(PE组)119例(25.9%)。
  • 初始结局指标在治疗后30天评估;2年随访时采用Kaplan-Meier曲线分析初次通畅率、辅助初次通畅率、二次通畅率和保肢率,并用log-rank检验进行组间比较。

主要发现

  • 两组人口学资料、术前危险因素和临床表现均衡;但PE组大隐静脉直径小于3 mm的患者比例高于DN组(21% vs 11.1%;P=.007)。
  • 术中远端吻合部位两组相似:膝下腘动脉DN组63%、PE组66.4%,胫血管DN组37%、PE组33.6%(P=.3)。
  • 总体平均随访时间11.6个月(范围1-24个月)。
  • 2年随访时两组初次通畅率(DN组66.3% vs PE组74.1%;P=.9)、辅助初次通畅率(DN组78.2% vs PE组79.5%;P=.2)、二次通畅率(DN组85.1% vs PE组91.4%;P=.2)和保肢率(DN组95.2% vs PE组95.1%;P=.9)均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to compare the 2-year outcomes of de novo versus postendovascular lesion treatment of femoropopliteal occlusions included in a national, multicenter, observational, prospective registry based on the treatment of critical Limb-threatening IschaeMia with infragenicular Bypass adopting in situ SAphenous VEin technique (LIMBSAVE) registry. METHODS: From January 2018 to December 2019, 541 patients from 43 centers have been enrolled in the LIMBSAVE registry. Of these patients, 460 were included in the present study: 341 (74.1%) with de novo lesions (DN group) and 119 (25.9%) with postendovascular treatment lesions (PE group). Initial outcome measures were assessed at 30 days after treatment. Furthermore, at the 2-year follow-up, the estimated outcomes of primary patency, primary-assisted patency, secondary patency, and limb salvage were analyzed with Kaplan-Meier curves and compared between groups with the log-rank test. RESULTS: Both groups were homogeneous in terms of demographic data, preoperative risk factors, and clinical presentation. However, compared with DN group, more patients in PE group had a great saphenous vein diameter of less than 3 mm (11.1% vs 21%; P = .007). Intraoperatively, both groups showed similar distal anastomosis sites: below-the-knee popliteal artery (63% DN group, 66.4% PE group) and tibial vessel (37% DN group, 33.6% PE group) (P = .3). The overall mean duration of follow-up was 11.6 months (range, 1-24 months). At the 2-year follow-up, there were no differences between the two groups in terms of primary patency (66.3% DN group vs 74.1% PE group; P = .9), primary-assisted patency (78.2% DN group vs 79.5% PE group; P = .2), secondary patency (85.1% DN group vs 91.4% PE group; P = .2), and limb salvage (95.2% DN group vs 95.1% PE group; P = .9). CONCLUSIONS: The LIMBSAVE registry did not show a worsening of overall patency and limb salvages rates at the 2-year follow-up in patients undergoing in situ saphenous bypass after a failed endovascular approach for long femoropopliteal occlusive disease. This finding is in contrast with what has been published in literature.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Troisi N, Michelagnoli S, Adami D, et al. Comparison of long occlusive femoropopliteal de novo versus previous endovascularly treated lesions managed with in situ saphenous bypass. J Vasc Surg. 2022. PMID: 35561942. doi:10.1016/j.jvs.2022.03.884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。